Kel Vin Tan Department of Diagnostic Radiology, School of Clinical Medicine, LKS Faculty of Medicine The University of Hong Kong Biography Publications Institution JoVE Articles Kel Vin Tan has not added a biography. If you are Kel Vin Tan and would like to personalize this page please email our Author Liaison for assistance. Publications CFI-402257, a TTK Inhibitor, Effectively Suppresses Hepatocellular Carcinoma Proceedings of the National Academy of Sciences of the United States of America. Aug, 2022 | Pubmed ID: 35914158 The Role of 68 Ga-DOTA-SSA PET/CT in the Management and Prediction of Peptide Receptor Radionuclide Therapy Response for Patients With Neuroendocrine Tumors : A Systematic Review and Meta-analysis Clinical Nuclear Medicine. Sep, 2022 | Pubmed ID: 35485851 Polo-like Kinase 4 Inhibitor CFI-400945 Suppresses Liver Cancer Through Cell Cycle Perturbation and Eliciting Antitumor Immunity Hepatology (Baltimore, Md.). Mar, 2022 | Pubmed ID: 35302667 EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder Tumors Molecular Imaging and Biology. 08, 2022 | Pubmed ID: 35147837 Longitudinal Evaluation of Five Nasopharyngeal Carcinoma Animal Models on the MicroPET/MR Platform European Journal of Nuclear Medicine and Molecular Imaging. 04, 2022 | Pubmed ID: 34862520 Lineage Tracing and Single-cell Analysis Reveal Proliferative Prom1+ Tumour-propagating Cells and Their Dynamic Cellular Transition During Liver Cancer Progression Gut. Aug, 2022 | Pubmed ID: 34588223 Development of Cisplatin-loaded Hydrogels for Trans-portal Vein Chemoembolization in an Orthotopic Liver Cancer Mouse Model Drug Delivery. Dec, 2021 | Pubmed ID: 33685316 PARP Inhibitors in Cancer Diagnosis and Therapy Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2021 | Pubmed ID: 33082213 CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis-Driven Hepatocarcinogenesis Via ERK-Dependent PKM2 Nuclear Relocalization and Activation Hepatology (Baltimore, Md.). 04, 2020 | Pubmed ID: 31469916 Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma Kel Vin Tan*1,2, Xinxiang Yang*3, Chung Ying Chan2, Jingjing Shi1, Hing-Chiu Chang4, Keith Wan-Hang Chiu1,5, Kwan Man3 1Department of Diagnostic Radiology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, 2Department of Oncology, MRC Oxford Institute for Radiation Oncology, University of Oxford, 3Department of Surgery, School of Clinical Medicine, HKU-SZH & LKS Faculty of Medicine, The University of Hong Kong, 4Department of Biomedical Engineering, The Chinese University of Hong Kong, 5Department of Diagnostic and Interventional Radiology, Kwong Wah Hospital JoVE 63958 Pesquisa do câncer
Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma Kel Vin Tan*1,2, Xinxiang Yang*3, Chung Ying Chan2, Jingjing Shi1, Hing-Chiu Chang4, Keith Wan-Hang Chiu1,5, Kwan Man3 1Department of Diagnostic Radiology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, 2Department of Oncology, MRC Oxford Institute for Radiation Oncology, University of Oxford, 3Department of Surgery, School of Clinical Medicine, HKU-SZH & LKS Faculty of Medicine, The University of Hong Kong, 4Department of Biomedical Engineering, The Chinese University of Hong Kong, 5Department of Diagnostic and Interventional Radiology, Kwong Wah Hospital JoVE 63958 Pesquisa do câncer